TREM2 sustains microglial expansion during aging and response to demyelination
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Microglia contribute to development, homeostasis, and immunity of the CNS. Like other tissue-resident macrophage populations, microglia express the surface receptor triggering receptor expressed on myeloid cells 2 (TREM2), which binds polyanions, such as dextran sulphate and bacterial LPS, and activates downstream signaling cascades through the adapter DAP12. Individuals homozygous for inactivating mutations in TREM2 exhibit demyelination of subcortical white matter and a lethal early onset dementia known as Nasu-Hakola disease. How TREM2 deficiency mediates demyelination and disease is unknown. Here, we addressed the basis for this genetic association using Trem2(-/-) mice. In WT mice, microglia expanded in the corpus callosum with age, whereas aged Trem2(-/-) mice had fewer microglia with an abnormal morphology. In the cuprizone model of oligodendrocyte degeneration and demyelination, Trem2(-/-) microglia failed to amplify transcripts indicative of activation, phagocytosis, and lipid catabolism in response to myelin damage. As a result, Trem2(-/-) mice exhibited impaired myelin debris clearance, axonal dystrophy, oligodendrocyte reduction, and persistent demyelination after prolonged cuprizone treatment. Moreover, myelin-associated lipids robustly triggered TREM2 signaling in vitro, suggesting that TREM2 may directly sense lipid components exposed during myelin damage. We conclude that TREM2 is required for promoting microglial expansion during aging and microglial response to insults of the white matter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the impaired ability of Trem2−/− or Apoe−/− microglia to remove damaged myelin hinders subsequent remyelination (Cantoni et al., 2015; Cantuti-Castelvetri et al., 2018; Poliani et al., 2015; Yeh et al., 2016).”
From Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response (2021) · cites this paper as Poliani et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TREM2 signals through its binding partner DAP12 (TYROBP) to elicit responses including phagocytosis, suppression of proinflammatory response, and promoting cell survival (Poliani et al., 2015; Takahashi et al., 2005).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Poliani et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TREM2 ligands include a variety of molecules, such as bacterial wall products, Aβ oligomers, lipoproteins, and anionic lipids, such as phospholipids and sphingolipids29,32–35”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TREM2 is a phospholipid sensing receptor known to sustain microglial cell activation and expansion in response to demyelination or amyloid plaques in Alzheimer’s disease (AD) [8, 42, 50].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [42]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mice lacking TREM2, fewer microglia accumulate in the corpus callosum during demyelination due to reduced proliferation which in turn reduces myelin debris clearance [200–202].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [201]
Experimental — accuracy not yet measured
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipid rafts as a membrane-organizing principle
Lingwood, D., & Simons, K. (2010) · Science · doi:10.1126/science.1174621 · Cited by 4,417 · cited 1×
“As DAP12 is located in lipid rafts, engagement of TREM2 may induce aggregation and mobilization of multiple receptors to lipid rafts (47), thereby facilitating their clustering and activation of multiple signaling pathways.”
Evidence for the Formation of Symmetric and Asymmetric DLPC-DAPC Lipid Bilayer Domains
Ritter, M., Schmidt, S., Jakab, M., Paulmichl, M., & Henderson, R. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350122 · Cited by 3,923
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 2×
“As Trem2 –/– mice did not develop spontaneous demyelination, we wanted to determine been reported in CNS cells other than microglia (33, 34), recently published studies demonstrated that Trem2 is specifically expressed in microglia — but not other cells in the CNS — under steady-state conditions…”
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 1×
“Very recent studies have shown that individuals heterozygous for a rare variant of TREM2, R47H, have high risk for developing Alzheimer disease (AD) (34, 48, 49).”
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736 · cited 2×
“We recently demonstrated that human TREM2 detects a similarly broad range of anionic and zwitter-ionic lipid ligands (52).”
Self-citationFatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657 · cited 1×
“Very recent studies have shown that individuals heterozygous for a rare variant of TREM2 , R47H, have high risk for developing Alzheimer disease (AD) (34, 48, 49).”
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., & Rossi, F. M. V. (2007) · Nature Neuroscience · doi:10.1038/nn2014 · Cited by 1,643
Cited by
Items 201–300 of 529
Petković, F., Campbell, I. L., Gonzalez, B., & Castellano, B. (2016) · Glia · doi:10.1002/glia.23043 · Cited by 59
“TREM2 was shown to be essential for microglial activation and efficient removal of myelin debris in the cuprizone (Cantoni et al., 2015; Poliani et al., 2015), as well as in the EAE model (Takahashi et al., 2007).”
BackgroundExercise prevents obesity-induced cognitive decline and white matter damage in mice
Graham, L. C., Grabowska, W. A., Chun, Y., Risacher, S. L., Philip, V. M., Saykin, A. J., Rizzo, S. J. S., & Howell, G. R. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.03.018 · Cited by 59
“Furthermore, myelin fragments accumulate throughout aging and the number of myeloid cells interacting with myelin increases (Poliani et al., 2015; Safaiyan et al., 2016).”
Gervois, P., & Lambrichts, I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01668 · Cited by 57
“Similar observations have been made in the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis (68) and in the cuprizone-induced non-autoimmune demyelination model (54, 69).”
BackgroundResultInfluentialMicroglia as therapeutic target in central nervous system disorders
Fatoba, O., Itokazu, T., & Yamashita, T. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.07.004 · Cited by 61
TREM2‐dependent microglial function is essential for remyelination and subsequent neuroprotection
Wang, Y., Kyauk, R. V., Shen, Y. A., Xie, L., Reichelt, M., Lin, H., Jiang, Z., Ngu, H., Shen, K., Greene, J. J., et al. (2023) · Glia · doi:10.1002/glia.24335 · Cited by 56
“Of note, however, our study (Figure 3) along with one by Poliani et al. (Poliani et al., 2015) does not observe neuronal loss or any axonal pathology due to TREM2 loss of function in uninjured mice.”
BackgroundResultSelf-citationOussini, H. E., Bayer, H., Scekic‐Zahirovic, J., Vercruysse, P., Sinniger, J., Dirrig‐Grosch, S., Dieterle, S., Echaniz‐Laguna, A., Larmet, Y., Müller, K., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1534-4 · Cited by 65
“However, recent work demonstrated that loss of Trem2 leads either to microglial degeneration in different diseases of the central nervous system [11, 60, 71], or conversely to protection [37].”
BackgroundTREM2: Modulator of Lipid Metabolism in Microglia
Damisah, E. C., Rai, A., & Grutzendler, J. (2020) · Neuron · doi:10.1016/j.neuron.2020.02.008 · Cited by 54
Smouldering Lesion in MS: Microglia, Lymphocytes and Pathobiochemical Mechanisms
Pukoli, D., & Vécsei, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612631 · Cited by 63
Disease-associated microglia in neurodegenerative diseases: Friend or foe?
Cheng, Y.-H., & Ho, M. S.-C. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003426 · Cited by 64
“Likewise, DAM-like microglia with similar transcriptional characterization have been detected in the EAE and cuprizone models of MS [75–78].”
Carbajosa, G., Malki, K., Lawless, N., Wang, H., Ryder, J. W., Wozniak, E., Wood, K., Mein, C. A., Dobson, R. J. B., Collier, D. A., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.04.019 · Cited by 49
Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis
Plastini, M. J., Desu, H. L., & Brambilla, R. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00269 · Cited by 48
“TREM2 ablation compromises microglia phagocytic capacity, resulting in impaired myelin debris clearance and persistent demyelination (Cantoni et al., 2015; Poliani et al., 2015).”
BackgroundMa, Q.-L., Zhu, C., Morselli, M., Su, T., Pelligrini, M., Lu, Z., Jones, M., Denver, P., Castro, D., Gu, X., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.558036 · Cited by 48
“TREM2 is a key player in the sustained-microglial expansion during aging (72) although its function is not yet fully understood.”
BackgroundPenney, J., Ralvenius, W. T., Loon, A., Cerit, O., Dileep, V., Milo, B., Pao, P., Woolf, H., & Tsai, L. (2024) · Glia · doi:10.1002/glia.24485 · Cited by 52
“TREM2 knockout mice exhibit impaired developmental synaptic pruning and impaired sensing and clearance of debris following myelin injury (Filipello et al., 2018; Nugent et al., 2020; Poliani et al., 2015).”
BackgroundInfluentialWhite matter-associated microglia: New players in brain aging and neurodegenerative diseases
Ahn, K., Lee, S.-J., & Mook-Jung, I. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101574 · Cited by 51
Toral-Rios, D., Long, J. M., Ulrich, J. D., Yu, J., Strickland, M. R., Han, X., Holtzman, D. M., Cashikar, A. G., & Paul, S. M. (2024) · Journal of Experimental Medicine · doi:10.1084/jem.20232000 · Cited by 47
“Expression of Ch25h is controlled by Trem2 (Zhou et al., 2020; Poliani et al., 2015), and our transcriptomic results suggested that Ch25h may amplify Trem2 signaling, suggesting that 25-HC is a lipid effector that can modulate inflammatory functions of microglia.”
BackgroundPark, J.-S., Ji, I. J., Kim, D.-H., An, H. J., & Yoon, S.-Y. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00618 · Cited by 47
“Hence, we speculate that the glycosylation status changes we observed herein for the R47H variant (Figures 1–3) could explain the ligand binding differences between wild-type TREM2 and TREM2 R47H (Atagi et al., 2015; Bailey et al., 2015; Poliani et al., 2015).”
BackgroundInfluentialZhang, L., Xu, J., Gao, J., Wu, Y., Yin, M., & Zhao, W. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0084 · Cited by 47
Mechanistic insights into the deleterious roles of Nasu-Hakola disease associated TREM2 variants
Dash, R., Choi, H. J., & Moon, I. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-60561-x · Cited by 49
TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection
Wu, Y., Wang, M., Yin, H., Ming, S., Li, X., Jiang, G., Liu, Y., Wang, P., Zhou, G., Liu, L., et al. (2021) · Science Advances · doi:10.1126/sciadv.abi6802 · Cited by 45
“It has been reported previously that TREM-2 can bind to certain bacterial components ( 32 , 33 ) and endogenous proteins ( 52 – 54 ), especially lipoprotein ( 34 , 55 , 56 ).”
Rong, Z., Cheng, B., Zhong, L., Ye, X., Li, X., Jia, L., Li, Y., Shue, F., Wang, N., Cheng, Y., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000550rr · Cited by 46
CCRL2 regulates M1/M2 polarization during EAE recovery phase
Mazzon, C., Zanotti, L., Wang, L., Prete, A. D., Fontana, E., Salvi, V., Poliani, P. L., & Sozzani, S. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ma0915-444rr · Cited by 50
“Recently, a new molecule, TREM2, has been described as a regulator of microglia activation in the CNS [27, 30].”
BackgroundSelf-citationSingh, A. K., Mishra, G., Maurya, A., Awasthi, R., Kumari, K., Thakur, A., Rai, A., Rai, G. K., Sharma, B., Kulkarni, G. T., et al. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190903102822 · Cited by 48
Regulation of microglial survival and proliferation in health and diseases
Ulland, T. K., Wang, Y., & Colonna, M. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2016.03.011 · Cited by 43
“Using a cuprizone-induced mouse model of oligodendrocyte toxicity and demyelination that recapitulates some of the pathological findings in individuals with NHD, we recently demonstrated that TREM2 promotes the microglial response to myelin debris [33].”
BackgroundSelf-citationTremblay, M.-È. (2021) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2021.100301 · Cited by 42
“…and vascular pathology, increasingly involved in brain disorders and diseases across the lifespan (Cuddapah et al., 2019; Degenhardt et al., 2020; Haruwaka et al., 2019; Iii et al., 2016; Ota et al., 2019; Ouellette et al., 2020; Poliani et al., 2015; Shi et al., 2015; Th eriault and Rivest, 2016).”
BackgroundHuang, S. Q., Liao, X., Wu, J., Zhang, X., Li, Y., Xiang, D., & Luo, S. (2022) · FEBS Letters · doi:10.1002/1873-3468.14336 · Cited by 43
Pesämaa, I., Müller, S. A., Robinson, S., Darcher, A., Paquet, D., Zetterberg, H., Lichtenthaler, S. F., & Haass, C. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00657-w · Cited by 40
Morris, G., Puri, B. K., Maes, M. H. J., OLIVE, L. S., Berk, M., & Carvalho, A. F. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109858 · Cited by 43
Microglial Phagocytosis—Rational but Challenging Therapeutic Target in Multiple Sclerosis
Pinto, M. V., & Fernandes, A. M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175960 · Cited by 45
Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?
Geladaris, A., Häusler, D., & Weber, M. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073461 · Cited by 47
“For example, TREM2-deficient microglia fail to upregulate genes associated with phagocytosis and lipid metabolism [49].”
BackgroundRadandish, M., Khalilian, P., & Esmaeil, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.667705 · Cited by 43
Teo, J. D., Marian, O. C., Spiteri, A. G., Nicholson, M., Song, H., Khor, J. X. Y., McEwen, H. P., Ge, A., Sen, M. K., Piccio, L. M., et al. (2022) · Glia · doi:10.1002/glia.24329 · Cited by 43
“26 Myelin phagocytosis by microglia can be initiated by interaction of the receptor Trem2 with myelin lipids such as ST and SM, when myelin or cellular debris is present (Cignarella et al., 2020; Poliani et al., 2015; Wang et al., 2015).”
BackgroundAfsar, A., Castro, M. D. C. C., Soladogun, A. S., & Li, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087258 · Cited by 49
Takata, K., Ginhoux, F., & Shimohama, S. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114754 · Cited by 45
Remyelination in the central nervous system
Franklin, R. J. M., Bodini, B., & Goldman, S. A. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041371 · Cited by 40
Human iPSC application in Alzheimer’s disease and tau-related neurodegenerative diseases
TCW, J. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.01.043 · Cited by 39
Targeting CaN/NFAT in Alzheimer’s brain degeneration
Mackiewicz, J., Lisek, M., & Boczek, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1281882 · Cited by 44
“The accumulation of phosphatidylserine (PS) and phosphatidylethanolamine (PE) on the neuronal cell membrane in the AD mouse brain (263) suggests that PC and PE may transduce signals via TREM2-NFAT (261, 264), potentially enhancing TREM2 activity and promoting a protective phenotype in microglia.”
BackgroundMetabolic Control of Smoldering Neuroinflammation
Peruzzotti-Jametti, L., Willis, C. M., Hamel, R., Krzak, G., & Pluchino, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705920 · Cited by 39
“Indeed, recent transcriptomics studies have provided indirect evidence supporting drastic changes in the lipid metabolism of activated microglia, as seen by the upregulation of lipid metabolism genes such as Trem2, Apoe, Spp1, Cts7, Lpl, and Fabp5 under inflammatory conditions (30, 70, 74, 75).”
InfluentialThe role of ApoE-mediated microglial lipid metabolism in brain aging and disease
Yen, J.-H. J., & Yu, I.-C. I. (2023) · Immunometabolism · doi:10.1097/in9.0000000000000018 · Cited by 43
“For instance, the triggering receptor expressed on myeloid cells 2 (TREM2) binds various lipid ligands, such as phospholipids and myelin debris, to incite the phagocytosis of damage-associated lipids by microglia [48,49].”
BackgroundInfluentialModeling the Pathogenesis of Charcot-Marie-Tooth Disease Type 1A Using Patient-Specific iPSCs
Shi, L., Huang, L., He, R., Huang, W., Wang, H., Lai, X., Zou, Z., Sun, J., Ke, Q., Zheng, M., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.11.013 · Cited by 38
“Moreover, most of these apolipoproteinmembers had been implicated in myelin biosynthesis and/or demyelination (Duan et al., 2007; Garcia-Mateo et al., 2014; Hunter et al., 2005; LeBlanc et al., 1989; Poliani et al., 2015; Zamel et al., 2008).”
BackgroundRaffaele, S., & Fumagalli, M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.950819 · Cited by 42
“This in turn was associated with decreased OPC recruitment, prolonged demyelination, and axonal degeneration (Cantoni et al., 2015; Poliani et al., 2015; Gouna et al., 2021).”
BackgroundAllende, M. L., Zhu, H., Kono, M., Hoachlander-Hobby, L. E., Huso, V. L., & Proia, R. L. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109879 · Cited by 37
“In the absence of TREM2, microglia accumulate sphingolipids after myelin fragmentation, suggesting that activation of TREM2 promotes the clearance of myelin fragments via the enhancement of the microglial lysosomal degradation pathway for sphingolipids [18, 19, 120].”
BackgroundGPR34 senses demyelination to promote neuroinflammation and pathologies
Lin, B., Zhou, Y., Huang, Z., Ma, M., Qi, M., Jiang, Z., Li, G., Xu, Y., Yan, J., Wang, D., et al. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01204-3 · Cited by 40
“Both myelin debris injection and tissue injury-induced myelin debris accumulation can induce in fl ammation in vivo by triggering microglia activation and in fl ammatory gene expression [11 – 13].”
Central Nervous System: (Immunological) Ivory Tower or Not?
Marin, I. A., & Kipnis, J. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.122 · Cited by 39
“Upon extension of microglial processes, microglial receptors such as CX3CR1, CR3, CD200R, or TREM2/DAP12 may recognize ligands on the neuronal membrane (Hoshiko et al, 2012; Paolicelli et al, 2011; Poliani et al, 2015; Schafer et al, 2012).”
BackgroundEndogenous neural stem cells modulate microglia and protect against demyelination
Brousse, B., Mercier, O., Magalon, K., Daian, F., Durbec, P., & Cayre, M. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.05.002 · Cited by 40
“However, they are also involved in phagocytosis and the removal of myelin debris, a prerequisite for successful remyelination (Kotter et al., 2006; Lampron et al., 2015; Poliani et al., 2015).”
BackgroundExploring the VISTA of microglia: immune checkpoints in CNS inflammation
Borggrewe, M., Kooistra, S. M., Noelle, R. J., Eggen, B. J. L., & Laman, J. D. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01968-x · Cited by 38
Microglial TREM2 at the Intersection of Brain Aging and Alzheimer’s Disease
Qu, W., & Li, L. (2021) · The Neuroscientist · doi:10.1177/10738584211040786 · Cited by 40
Hwang, M., Savarin, C., Kim, J., Powers, J., Towne, N., Oh, H., & Bergmann, C. C. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02629-1 · Cited by 44
“Overall the day 21 pi timepoint was most notably marked by reduced, rather than increased levels of pro-inflammatory factors in the absence of Trem2 reminiscent of the CPZ studies [7, 9].”
BackgroundZhao, L., Yu, S., Li, L., Zhou, C., Wang, L., Tang, S., Gu, N., Zhang, Z., Huang, Z., Chen, H., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1665 · Cited by 41
“27 Furthermore, TREM2 deficiency diminishes the phagocytic activity involving apoptotic cells, cellular debris, lipoproteins, A β , and bacterial products.”
BackgroundSelf-citationImmunosenescence: A Critical Factor Associated With Organ Injury After Sepsis
Lü, X., Yang, Y.-M., & Lu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.917293 · Cited by 37
Replenishing the Aged Brains: Targeting Oligodendrocytes and Myelination?
Zhang, X., Huang, N., Xiao, L., Wang, F., & Li, T. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.760200 · Cited by 34
“The superficial layer of cortex is the last region to be myelinated, where new myelin sheaths are continuously added into adulthood (Purger et al., 2016; Hill et al., 2018).”
BackgroundMicroglia in the context of multiple sclerosis
Zhang, X., Chen, F., Sun, M., Wu, N., Liu, B., Yi, X., Ge, R., & Fan, X. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1157287 · Cited by 45
“In Trem2−/− mice, clearance of myelin debris and axonal support are impaired, the number of oligodendrocytes is increased, and inflammatory mediators are expressed after long-term cuprizone treatment, resulting in persistent demyelination (69).”
BackgroundLipid droplet accumulation in microglia and their potential roles
Li, Y., Zhao, Q., Wang, Y., Du, W., Yang, R., Wu, J., & Li, Y. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02633-3 · Cited by 41
Self-citationBelloli, S., Pannese, M., Buonsanti, C., Maiorino, C., Di Grigoli, G., Carpinelli, A., Monterisi, C., Moresco, R. M., & Panina-Bordignon, P. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.01.010 · Cited by 34
Konishi, H., & Kiyama, H. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104878 · Cited by 34
Wan, T., Fu, M., Jiang, Y., Jiang, W., Li, P., & Zhou, S. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03448-1 · Cited by 40
Scott‐Hewitt, N., Folts, C. J., Hogestyn, J. M., Piester, G., Mayer-Pröschel, M., & Noble, M. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx153 · Cited by 33
Qki is an essential regulator of microglial phagocytosis in demyelination
Ren, J., Dai, C., Zhou, X., Barnes, J. A., Chen, X., Wang, Y., Yuan, L., Shingu, T., Heimberger, A. B., Chen, Y., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20190348 · Cited by 36
“For instance, decrease in the phagocytic activity of microglia in both humans and mice has been shown to delay recovery from demyelinating conditions (Janda et al., 2018; Linehan et al., 2014; Poliani et al., 2015).”
BackgroundSelf-citationWang, R., Li, H., Ling, C., Zhang, X., Lü, J., Luan, W., Zhang, J., & Shi, L. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.371365 · Cited by 37
Cheng, B., Li, X., Dai, K., Duan, S., Rong, Z., Chen, Y., Lü, L., Liu, Z., Huang, X., Xu, H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633796 · Cited by 40
“In contrast, Trem2 mice are grossly normal in growth without apparent microglia reduction in young or adult brains but with fewer and abnormal microglia in aged brains (32).”
BackgroundDoust, Y. V., Rowe, R. K., Adelson, P. D., Lifshitz, J., & Ziebell, J. M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.722526 · Cited by 35
“Triggering receptor expressed on myeloid cells 2 (TREM2) is a surface receptor that detects damage-associated lipid patterns associated with neurodegeneration (67, 68).”
BackgroundGao, H., Di, J., Clausen, B. H., Wang, N., Zhu, X., Zhao, T., Chang, Y., Pang, M., Yang, Y., He, R., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112629 · Cited by 38
Self-citationHypoxia and myelination deficits in the developing brain
Singh, D. K., Ling, E., & Kaur, C. (2018) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2018.06.012 · Cited by 41
“Several studies have reported the positive role of microglia in clearing myelin debris and enhancing remyelination by activating different signalling pathways (Poliani et al., 2015; Kocur et al., 2015; Hadas et al., 2012).”
BackgroundRoles of TREM2 in Alzheimer’s disease
Qi, X., Zhu, K., Ke, W., Wang, J., Mao, S., & Chen, G. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00515-3 · Cited by 42
“Additionally, these mice show a marked impairment in the clearance of damaged myelin and a significant reduction in the capacity to promote remyelination, similar to the demyelinating pathology seen in NHD [6, 280, 375].”
Wu, Y., Wu, M., Ming, S., Zhan, X., Hu, S., Li, X., Yin, H., Cao, C., Liu, J., Li, J., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci137407 · Cited by 35
Contributions of triggering-receptor-expressed-on-myeloid-cells-2 to neurological diseases
Han, J., Wang, M., Ren, M., & Lou, H. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1264072 · Cited by 30
“In MS mice TREM2 is associated with the secretion of trophic factors that promote oligodendrocyte differentiation and survival [61].”
BackgroundDong, X., Zhang, Z., Shu, X., Zhuang, Z., Liu, P., Liu, R., Xia, S., Bao, X., Xu, Y., & Chen, Y. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01147-1 · Cited by 33
Modulation of Microglial Function by ATP-Gated P2X7 Receptors: Studies in Rat, Mice and Human
Tewari, M., Michalski, S. A., & Egan, T. M. (2024) · Cells · doi:10.3390/cells13020161 · Cited by 40
“For example, genetically modified rats lacking TREM2 fail to show the DAM phenotype [182].”
BackgroundMyelin debris phagocytosis in demyelinating disease
Gao, R., Song, S., Tian, M., Wang, L., Zhang, Y., & Li, X. (2024) · Glia · doi:10.1002/glia.24602 · Cited by 35
“TREM2 is particularly important for the functions of microglia, including the con-trol of proliferation, survival, energy metabolism, and phagocytosis (Poliani et al., 2015; Wang, Cella, et al., 2015).”
Autophagy & Phagocytosis in Neurological Disorders and their Possible Cross-talk
Li, G., Sherchan, P., Tang, Z., & Tang, J. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210407150632 · Cited by 32
“TREM2 overexpression was found to be protective, partially caused by effects on clearance of myelin debris [65-67].”
BackgroundTargeting microglia–oligodendrocyte crosstalk in neurodegenerative and psychiatric disorders
Rahimian, R., Perlman, K., Canonne, C., & Mechawar, N. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.06.015 · Cited by 33
The emerging role of disease-associated microglia in Parkinson’s disease
Samant, R. R., Standaert, D. G., & Harms, A. S. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1476461 · Cited by 36
“Specifically, it is the TREM2-APOE pathway that appears to facilitate the shift from homeostatic to DAM following microglial phagocytosis of apoptotic neuronal bodies (Poliani et al., 2015).”
Yu, H., Zhang, L., Song, B., Ren, K., Chen, X., Dai, Y., Yang, Y., Xu, Y., & Wei, Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06799-3 · Cited by 37
“…to activate the mTOR pathway, leading to abnormal autophagy and dysregulation of intracellular energy and biosynthetic metabolism, and this metabolic defect can be reversed in vitro by activating the Dectin-1 receptor, which triggers a signaling pathway similar to the TREM2-DAP12 axis [19, 129].”
Lipid metabolism and neuroinflammation: What is the link?
Tiwari, V., & Simons, M. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20241232 · Cited by 43
The Microglial Response to Neurodegenerative Disease
Song, W. M., & Colonna, M. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.04.002 · Cited by 30
Self-citationTREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1/BTK axis
Ming, S., Li, X., Xiao, Q., Qu, S., Wang, Q., Fang, Q., Liang, P., Xu, Y., Yang, J., Yang, Y., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci159400 · Cited by 31
“In addition, TREM2 deficiency is associated with reduced expression of lipid metabolic enzymes and impaired clearance of myelin debris (61).”
RetractedManouchehri, N., Salinas, V. H., Yeganeh, N. R., Pitt, D., Hussain, R. Z., & Stüve, O. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.854390 · Cited by 28
“Interestingly, it was recently shown that microglial density in the brain increases in aged mice (117).”
BackgroundTarale, P., & Alam, M. M. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-00958-4 · Cited by 26
Bauch, J., & Faissner, A. (2022) · Cells · doi:10.3390/cells11111773 · Cited by 29
“Currently, chronic demyelination is induced by a 12-week cuprizone treatment [40,41].”
BackgroundZhang, X., Yan, F., Cui, J., Wu, Y., Luan, H., Yin, M., Zhao, Z., Feng, J., & Zhang, J. (2017) · Mediators of Inflammation · doi:10.1155/2017/9340610 · Cited by 28
“Trem2−/− microglia showed reduced transcripts indicative of phagocytosis and lipid catabolism [37].”
BackgroundMontilla, A., Zabala, A., Calvo, I., Bosch-Juan, M., Velasco, I. T., Mata, P., Koster, M., Sierra, A., Kooistra, S. M., Soria, F. N., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05648-2 · Cited by 30
“LD-accumulating microglia represent a dysfunctional state in the aging brain [83], and a similar phenotype has been described in microglia lacking TREM2 [52, 58, 65].”
Differential Roles of TREM2+ Microglia in Anterograde and Retrograde Axonal Injury Models
Manich, G., Gómez‐López, A. R., Almolda, B., Villacampa, N., Recasens, M., Shrivastava, K., González, B., & Castellano, B. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.567404 · Cited by 28
“Cuprizone studies showed that the absence of TREM2 expression in microglia increases axonal injury and impairs a proper repair (Cantoni et al., 2015; Poliani et al., 2015) that can be rescued with TREM2 activating antibodies (Cignarella et al., 2020).”
BackgroundTargeting PKC in microglia to promote remyelination and repair in the CNS
Kim, P. M., & Kornberg, M. D. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.11.008 · Cited by 26
Zhang, T., Feng, T., Wu, K., Guo, J. D., Nana, A. L., Yang, G., Seeley, W. W., & Hu, F. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02578-w · Cited by 29
Savarin, C., Dutta, R., & Bergmann, C. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01325 · Cited by 28
“However, TREM2-modulated phagocytic functions are essential for removal of myelin debris and remyelination implicating repair-promoting functions of microglia in the specific tissue environments defining these two demyelination models (17, 62) .”
BackgroundClusterin/apolipoprotein J, its isoforms and Alzheimer's disease
Milinkeviciute, G., & Green, K. N. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1167886 · Cited by 27
“, 2017), phagocytosis (Poliani et al., 2015; Wang et al., 2015), activation (Jay et al.”
Tan, L. Y., Cunliffe, G., Hogan, M. P., Yeo, X. Y., Oh, C., Jin, B., Kang, J., Park, J., Kwon, M., Kim, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1380063 · Cited by 26
Lin, C., Kong, Y., Chen, Q., Zeng, J., Pan, X., & Miao, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1420731 · Cited by 27
“…of binding a wide array of molecules with polyanionic traits, including bacterial membranes, myelin, lipoproteins such as ApoE, A β , DNA, and others (Poliani et al., 2015; Wang et al., 2015; Yeh et al., 2016; Cignarella et al., 2020), suggesting that TREM2’s activation is highly context-dependent.”
BackgroundTrem2-deficiency aggravates and accelerates age-related myelin degeneration
McCray, T. J., Bedford, L. M., Bissel, S. J., & Lamb, B. T. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01855-3 · Cited by 23
“This observation contrasts with other studies that report age-related increases in microglia, particularly in white-matter regions such as the corpus callosum and cerebellum [52, 57].”
BackgroundResultInfluentialTREM2 in Neurodegenerative Disorders: Mutation Spectrum, Pathophysiology, and Therapeutic Targeting
Yang, H.-W., Kim, D., Yang, Y., Bagyinszky, E., & An, S. S. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157057 · Cited by 28
TMEM106B regulates microglial proliferation and survival in response to demyelination
Zhang, T., Pang, W., Feng, T., Guo, J. D., Wu, K., Santos, M. N., Arthanarisami, A., Nana, A. L., Nguyen, Q., Kim, P. J., et al. (2023) · Science Advances · doi:10.1126/sciadv.add2676 · Cited by 23
“The expression of several disease-associated microglia (DAM) markers, including Trem2, Lgals3, and Gpnmb, which are known to be upregulated in response to demyelination (56, 57), is lower in Tmem106b microglia compared to WT control upon CPZ treatment as revealed by RNA-seq analysis (fig.”
ResultLipid in microglial biology — from material to mediator
Yamamoto, S., & Masuda, T. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00289-z · Cited by 28
“During the pathogenesis, microglia concomitantly upregulate expression levels of lipid-related genes (Abca1, Apoe, Apoc1, Cd36, and Lpl) and undergo proliferation [22, 23, 33, 48], which might indicate that microglia positively shift their lipid metabolic states to utilize lipids for energy source and materials of cel…”
BackgroundInfluentialZhang, X., Chen, X., Zhang, L., Sun, Y., Liang, Y., Li, H., & Zhang, Y. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105639 · Cited by 23
Noble, M., Scott‐Hewitt, N., & Folts, C. J. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.228712 · Cited by 23
“Microglia from GALC mice had decreased expression of Triggering receptor expressed on myeloid cells-2 (Trem2), which is thought to play such an important role in microglial clearance of myelin debris that elevated expression of Trem2 has been used as a readout of myelin phagocytosis after cuprizone exposure (Cantoni e…”
BackgroundInfluentialMicroglial and TREM2 dialogues in the developing brain
Morini, R., Tagliatti, E., Bizzotto, M., & Matteoli, M. (2025) · Immunity · doi:10.1016/j.immuni.2025.04.022 · Cited by 25
Insights into Macrophage/Monocyte-Endothelial Cell Crosstalk in the Liver: A Role for Trem-2
Coelho, I., Duarte, N., Macedo, M. P., & Penha‐Gonçalves, C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061248 · Cited by 24
“Moreover, some reports suggest that activation of Trem-2 induces Trem-2 ligands production, therefore sustaining Trem-2-dependent activation [93,94].”
BackgroundZhao, J., Ren, T., Li, X., Guo, T.-L., Liu, C., & Wang, X. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.831977 · Cited by 24
“Due to substantial plaque compaction changes, microglia are less capable of phagocytosis and hence unable to eliminate Aβ and apoptotic cells (Poliani et al., 2015; Yuan et al., 2016), thereby adversely affecting the AD process.”
BackgroundMicroglia: Friends or Foes in Glaucoma? A Developmental Perspective
Ahmad, I., & Subramani, M. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac077 · Cited by 23
Shi, J., & Huang, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010016 · Cited by 23
“TREM2’s role is underscored by the loss of microglial density and activation seen in TREM2-deficient or loss-of-function mutant models, highlighting its necessity for the formation of a protective microglial barrier around plaques [82,83].”
BackgroundXu, M., Wang, M. M., Gao, Y., Keep, R. F., & Shi, Y. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.008 · Cited by 23
Role of IL-34 and its receptors in inflammatory diseases
Shang, J., Xu, Y., Pu, S., Sun, X., & Gao, X. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156348 · Cited by 28
Metadata
- Authors
- Poliani, P. L., Wang, Y., Fontana, E., Robinette, M. L., Yamanishi, Y., Gilfillan, S., & Colonna, M.
- Affiliations
- University of Brescia (IT)
- Washington University in St. Louis (US)
- Corresponding author
- Poliani, Pietro Luigi
- Wang, Yaming
- Colonna, Marco
- Venue
- Journal of Clinical Investigation
- Published
- 2015-04-20
- Volume
- 125
- Issue
- 5
- Pages
- 2161-2170
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4463196
- OpenAlex
- W2094831055
- Cited by
- 525
- References
- 58
- Citations by year
- 2026: 45 · 2025: 41 · 2024: 41 · 2023: 55 · 2022: 69 · 2021: 65 · 2020: 50 · 2019: 43 · 2018: 40 · 2017: 32 · 2016: 32 · 2015: 10
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion, public-domain)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- Eli Lilly and Company
- Cure Alzheimer's Fund
- Fondazione Cariplo
- National Institutes of Health (5p60dk020579-35, AG005681, DK020579)
- Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. Louis
- Japan Society for the Promotion of Science (15K20969, 26893063)
- RIKEN
- National Institute on Aging (P50AG005681)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK‐020579, P60-DK-020579, P30DK020579)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- TREM2, microglia, aging, demyelination, cuprizone, myelin debris clearance, white matter, oligodendrocyte degeneration, myelin lipids, Nasu-Hakola disease, TREM2 knockout mice, microglial activation, phagocytosis, lipid degradation, axonal dystrophy
- MeSH terms
- Aging, Animals, Axons, Brain, Cell Count, Cuprizone, Demyelinating Diseases, Disease Models, Animal, Humans, Lipodystrophy, Membrane Glycoproteins, Myelin Sheath, Nerve Tissue Proteins, Osteochondrodysplasias, Phagocytosis, Receptors, Immunologic, Regeneration, Subacute Sclerosing Panencephalitis, Transcription, Genetic, Microglia, Genes, Reporter, Mice, Knockout, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.